Natalia Paterson Sonicheva
About Natalia Paterson Sonicheva
Natalia Paterson Sonicheva is the Medical Director WW at Bristol Myers Squibb in New Jersey, United States, with over 15 years of international pharmaceutical experience.
Title
Natalia Paterson Sonicheva is the Medical Director WW at Bristol Myers Squibb, based in New Jersey, United States.
Current Position at Bristol Myers Squibb
Natalia Paterson Sonicheva currently serves as Medical Director WW at Bristol Myers Squibb in New Jersey, United States. Her role involves overseeing global medical strategies and operations, contributing to the advancement of the company's medical agenda.
Previous Roles in Medical and Market Access Management
Throughout her career, Natalia has held various significant positions. She was a Regional Medical Lead Europe at MyoKardia in 2020. Prior to that, she worked as a Cardiologist, Medical Affairs & Commercial Area Manager for UK, Italy, Russia & Ukraine at Health In Code, S.L. from 2014 to 2020. She has also served as a Market Access Manager for AstraZeneca and Pfizer, and as a Medical, Marketing & Market Access Manager for the Genetics Business Unit at Genzyme.
Educational Background
Natalia Paterson Sonicheva holds a medical degree from the Medical Faculty of Smolensk State Medical Academy. She has specialized as a Cardiologist through the First Moscow State Medical University. Additionally, she has acquired marketing expertise at the Russian State University of Management, Russian-Holland University RIMA Marketing faculty, with a focus on Marketing Planning, Media Planning, Press and Radio Advertising, and Marketing Management.
International Experience and Pharmaceutical Expertise
Natalia has over 15 years of international pharmaceutical experience, having taken up various roles at regional, national, and international levels. She has lived and worked in Italy, Spain, Ireland, and Russia, bringing a wealth of diverse perspectives to her role. Furthermore, she has co-founded and serves as Secretary of the National Cardio-Genetics Society and is a member of the ESC Cardiomyopathy Working Group.